News
CT is your last chance to file a claim with 23andMe for a 2023 data breach that may have compromised your genetic data.
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...
Regeneron's bid to acquire the bankrupt genetic testing firm 23andMe for $256 million has likely come to an end.
Anne Wojcicki, founder and former CEO of 23andMe, will helm the company again after her nonprofit's purchase was approved.
A bankruptcy court approved the $305M sale of 23andMe to a nonprofit led by Anne Wojcicki, raising questions about data ...
The consumer privacy ombudsman in 23andMe’s sale of customers’ genetic data is defending his choice of counsel against ...
A federal judge on Thursday declined to block the bankruptcy sale of genetic testing company 23andMe to its co-founder Anne ...
A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to a nonprofit organization led ...
The DNA data of millions of people who used 23andMe's services won't be sold to a pharmaceutical company. A bankruptcy judge greenlighted the sale of the remnants of the firm, including its wealth of ...
States with privacy objections to the sale have until July 7 to reach a stay to appeal the case. TTAM, a nonprofit started by ...
13don MSN
Anne Wojcicki's nonprofit TTAM Research Institute will purchase "substantially all" of San Francisco-based 23andMe's assets.
A bankruptcy judge approved the sale of 23andMe's assets and business operations to a nonprofit led by 23andMe’s co-founder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results